Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00455234Phase 3Completed
Phase 3, randomised, single-blind trial of olanzapine in agitation (2 arms), sponsored by Christian Medical College, Vellore. Primary endpoint: Number of participants tranquil or asleep at 4 hours. Started Sep 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00455234.